• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The potential interaction between oral anticoagulants and acetaminophen in everyday practice.

作者信息

van den Bemt P M L A, Geven L M, Kuitert N A, Risselada A, Brouwers J R B J

机构信息

Hospital Pharmacy Midden-Brabant, TweeSteden Hospital, St. Elisabeth Hospital, Tilburg, The Netherlands.

出版信息

Pharm World Sci. 2002 Oct;24(5):201-4. doi: 10.1023/a:1020555321857.

DOI:10.1023/a:1020555321857
PMID:12426965
Abstract

OBJECTIVE

The drug-drug interaction between oral anticoagulants (especially warfarin) and acetaminophen has been described, but evidence is conflicting and evidence for a similar interaction between acenocoumarol or phenprocoumon and acetaminophen is limited. Therefore, a study was performed to determine the influence of acetaminophen on oral anticoagulation with acenocoumarol or phenprocoumon in everyday practice.

METHOD

Included were patients from two Dutch anticoagulant clinics who had used oral anticoagulants for at least three months and who started with acetaminophen (case group) or benzodiazepines (control group).

RESULTS

Fifty-four patients were included who had a first prescription of acetaminophen in their pharmacy record (during oral anticoagulant use) and twenty patients with a first prescription of a benzodiazepine (during oral anticoagulant use). The INR (International Normalized Ratio) difference before and after acetaminophen use was not statistically significant between the two groups and showed no dose dependency.

CONCLUSION

These data do not demonstrate that acetaminophen, in the dosages used in everyday practice, has a clinically relevant influence on the INR in patients using acenocoumarol or phenprocoumon.

摘要

相似文献

1
The potential interaction between oral anticoagulants and acetaminophen in everyday practice.
Pharm World Sci. 2002 Oct;24(5):201-4. doi: 10.1023/a:1020555321857.
2
Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: a randomized double-blind clinical trial.
J Thromb Haemost. 2003 Apr;1(4):714-7. doi: 10.1046/j.1538-7836.2003.00135.x.
3
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.华法林、醋硝香豆素和苯丙香豆素之间的药物遗传学差异。
Thromb Haemost. 2008 Dec;100(6):1052-7.
4
Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon.高剂量埃索美拉唑与苯丙香豆素之间可能存在药物相互作用。
Eur J Clin Pharmacol. 2015 Dec;71(12):1461-5. doi: 10.1007/s00228-015-1912-1. Epub 2015 Sep 24.
5
Acetaminophen and other risk factors for excessive warfarin anticoagulation.对乙酰氨基酚及其他导致华法林抗凝过度的风险因素。
JAMA. 1998 Mar 4;279(9):657-62. doi: 10.1001/jama.279.9.657.
6
The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.三种维生素K拮抗剂(醋硝香豆素、华法林和苯丙香豆素)维持剂量之间的关系。
Thromb Res. 2008;123(2):225-30. doi: 10.1016/j.thromres.2008.01.020. Epub 2008 Apr 14.
7
The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.对乙酰氨基酚对华法林治疗稳定患者国际标准化比值的影响。
Pharmacotherapy. 2007 May;27(5):675-83. doi: 10.1592/phco.27.5.675.
8
Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon.使用醋硝香豆素与苯丙香豆素进行口服抗凝治疗的对照与稳定性比较。
Thromb Haemost. 2003 Aug;90(2):260-6. doi: 10.1160/TH02-10-0179.
9
Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.比较短效醋硝香豆素和长效苯丙香豆素的口服抗凝治疗的疗效质量控制
Br J Haematol. 2002 Jun;117(4):940-6. doi: 10.1046/j.1365-2141.2002.03493.x.
10
Warfarin and acetaminophen interaction.华法林与对乙酰氨基酚的相互作用。
Pharmacotherapy. 2003 Jan;23(1):109-12. doi: 10.1592/phco.23.1.109.31913.

引用本文的文献

1
Response to: 'Correspondence on 'Warfarin use and risk of knee and hip replacements'' by Cheng and Zhang.对Cheng和Zhang所著的《关于“华法林的使用与膝关节和髋关节置换术风险”的通信》的回复
Ann Rheum Dis. 2023 Jun;82(6):e151. doi: 10.1136/annrheumdis-2021-220601. Epub 2021 May 13.
2
[Non-opioid pain medication in the elderly].[老年人的非阿片类止痛药物]
Schmerz. 2015 Aug;29(4):371-9. doi: 10.1007/s00482-015-0032-2.
3
Using highly variable warfarin dosing to identify patients at risk for adverse events.采用高度变化的华法林剂量来识别有不良事件风险的患者。

本文引用的文献

1
Hospitalisation for upper gastrointestinal bleeding associated with use of oral anticoagulants.与口服抗凝剂使用相关的上消化道出血住院治疗。
Thromb Haemost. 2001 Aug;86(2):563-8.
2
Enzymatic shunting: resolving the acetaminophen-warfarin controversy.
Pharmacotherapy. 2000 Dec;20(12):1464-8. doi: 10.1592/phco.20.19.1464.34860.
3
Warfarin-acetaminophen drug interaction revisited.
Pharmacotherapy. 1999 Oct;19(10):1153-8. doi: 10.1592/phco.19.15.1153.30584.
4
Thromb J. 2011 Oct 10;9:14. doi: 10.1186/1477-9560-9-14.
4
Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.华法林与对乙酰氨基酚相互作用:证据总结与生物学合理性。
Blood. 2011 Dec 8;118(24):6269-73. doi: 10.1182/blood-2011-08-335612. Epub 2011 Sep 12.
5
Drug interactions-information, education, and the British National Formulary.药物相互作用——信息、教育与《英国国家处方集》
Br J Clin Pharmacol. 2004 Apr;57(4):371-2. doi: 10.1111/j.1365-2125.2004.02125.x.
6
Pharmacological treatments for persistent non-malignant pain in older persons.老年人持续性非恶性疼痛的药物治疗
Drugs Aging. 2004;21(1):19-41. doi: 10.2165/00002512-200421010-00003.
Potentiation of the acenocoumarol anticoagulant effect by acetaminophen.
Ann Pharmacother. 1999 Apr;33(4):506. doi: 10.1345/aph.18280.
5
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.细胞色素P450 CYP2C9基因多态性与华法林剂量需求及出血并发症风险的关联
Lancet. 1999 Feb 27;353(9154):717-9. doi: 10.1016/S0140-6736(98)04474-2.
6
The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin.
J Clin Pharmacol. 1999 Jan;39(1):68-75. doi: 10.1177/00912709922007570.
7
Acetaminophen and other risk factors for excessive warfarin anticoagulation.对乙酰氨基酚及其他导致华法林抗凝过度的风险因素。
JAMA. 1998 Mar 4;279(9):657-62. doi: 10.1001/jama.279.9.657.
8
Clinically important drug interactions with anticoagulants. An update.与抗凝剂相关的具有临床重要意义的药物相互作用。最新进展。
Clin Pharmacokinet. 1996 Jun;30(6):416-44. doi: 10.2165/00003088-199630060-00002.